In contrast, the eNOS-786 polymorphism showed no significant correlation with these clinical conditions, indicating that variations in this gene may not play a major role in the prevalence of hypertension, diabetes, or hyperlipidemia within the studied population. This evidence concerns the gene NOS3 and hyperlipidemia.